Avantika

A biology enthusiast with a passion for learning, exploring, and enjoying this beautiful field with unparalleled dedication.

Ongoing Project (Masters):

Preferential elimination of pathological B-cells using rituximab-based tetravalent bispecific antibodies:

-Engineering and production of antibodies through genetic cloning techniques and subsequent transfection into mammalian cell lines.

-Testing the hypothesis of preferential elimination of pathological B-cells compared to normal cells through Binding (flow cytometry/ELISA) and cytotoxic (Cell-Dependent-Cytotoxicity) assays.

Previous Project:

Promoting remyelination in the neurons in Multiple Sclerosis, 01/2022-12/2022:

-Studying and understanding various strategies and pathways for the treatment of Multiple Sclerosis and innovating drug candidates using computational approach for promoting remyelination as a potential way to treat multiple sclerosis Peptide-based vaccine design against SARS COV-2

-Chose the surface glycoprotein of SARS-COV-2 and using various computational tools like MUSCLE, PDB, MODPEP, Discovery Studio, CABSDock to identify epitopes as a suitable peptide-based vaccine against SARSCOV-2